Angle Closure Glaucoma- Current Concepts
This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA
Overview
Download & View Angle Closure Glaucoma- Current Concepts as PDF for free.
More details
- Words: 3,312
- Pages: 77
Angle Closure Glaucoma Current Concepts Dr Sanjay Shrivastava Professor of Ophthalmology Regional Institute of Ophthalmology Gandhi Medical College, Bhopal September 24,2006
Dr Sanjay Shrivastava
1
Definition • Angle Closure Glaucomas are characterized by apposition of peripheral iris against trabecular meshwork, resulting in obstruction of aqueous outflow.
September 24,2006
Dr Sanjay Shrivastava
2
• Primary Angle Closure Glaucoma term is used when mechanism of angle closure glaucoma is not felt to be associated with other ocular or systemic abnormalities or because the mechanisms are not well understood. In this condition pupillary block glaucoma, plateau iris and combined mechanism glaucoma have been included. September 24,2006
Dr Sanjay Shrivastava
3
• Secondary Angle Closure Glaucoma is associated with ocular or systemic abnormalities or due to apparent mechanism such as membrane contraction or space occupying lesions pushing iris forward to close angle.
September 24,2006
Dr Sanjay Shrivastava
4
Epidemiology • Glaucoma is second leading cause of blindness world wide. It has been estimated that by 2010 there will be 60.5 million glaucoma affected people with approximately 26% with angle closure glaucoma. • Angle closure glaucoma is less common than chronic open angle glaucoma. • Angle closure glaucoma is common among Asians and Eskimos but uncommon among Africans and Caucasians September 24,2006
Dr Sanjay Shrivastava
5
Epidemiology • The precise ratio between the two has not been established. Reported figures from some of the western countries indicates incidence of angle closure glaucoma as 0.5% in general population and 2-3 % in >40 years age group. • Prevalence of 1.58% has been reported in rural south Indian population by Lingam & co-workers (2006) September 24,2006
Dr Sanjay Shrivastava
6
Epidemiology • West Bengal study has reported glaucoma in 2.63% cases in 1594 individuals >50 years examined. • Another study has estimated that ½ of 67 million people diagnosed with glaucoma has primary angle closure glaucoma. According to this study 6.7 million people globally are irreversibly blind due glaucoma. September 24,2006
Dr Sanjay Shrivastava
7
Stages of Glaucoma 1. Initiating events 2. Structural alterations 3. Functional alterations 4. Optic nerve damage 5. Visual loss
September 24,2006
Dr Sanjay Shrivastava
8
Stages of Glaucoma Stages representing: * The series of events, leading to * Tissue changes, leading to * Physiologic changes, leading to * Axonal loss, leading to * Visual field loss (progressive)
September 24,2006
Dr Sanjay Shrivastava
9
Stages of Glaucoma * Stage I – Initiating events may be genetic or acquired * Stage II- Tissue changes are associated with aqueous outflow system with vascular and structural alteration in optic nerve head. * Stage III- Physiologic changes are associated with elevated IOT, reduced vascular perfusion, laminar deformity
September 24,2006
Dr Sanjay Shrivastava
10
Stages of Glaucoma * Stage IV – Axonal Loss leads to *Stage V - Glaucomatous optic neuropathy that is associated with Glaucomatous field loss
September 24,2006
Dr Sanjay Shrivastava
11
Classification of the Glaucomas Based on Initial events A. Open Angle Glaucomas B. Angle Closure Glaucomas 1. Pupillary Block Glaucoma 2. Plateau Iris Syndrome 3. Combined mechanism Glaucomas C. Developmental Glaucomas D. Glaucomas Associated with other ocular and systemic disorders September 24,2006
Dr Sanjay Shrivastava
12
Pupillary Block Glaucoma • Also called primary angle closure Glaucomas – Acute – Sub-acute – Chronic angle closure • Creeping angle closure • Combined mechanism glaucoma
September 24,2006
Dr Sanjay Shrivastava
13
Classification of the Glaucomas based on mechanism of outflow obstruction I. Open Angle Glaucoma mechanism II. Angle Closure Glaucoma Mechanism III. Developmental Anomalies of the Anterior Chamber Angle
September 24,2006
Dr Sanjay Shrivastava
14
Angle Closure Glaucoma Mechanism A. Anterior (Pulling Mechanism) 1. Contracture of Membranes (Neovascular Glaucoma, ICE Syndrome, Post polymorphous dystrophy, Ocular Trauma) 2. Contracture of Inflammatory precipitates
September 24,2006
Dr Sanjay Shrivastava
15
Angle Closure Glaucoma Mechanism… Contd. B. Posterior (Pushing Mechanism) 1. With Pupillary block : Pupillary Block Glaucoma- Lens Induced Mechanism (Intumescent lens, subluxation of lens, mobile lens syndrome), Post synechiae (Iris-vitreous block, pseudophakia, Uvietis)
September 24,2006
Dr Sanjay Shrivastava
16
Angle Closure Glaucoma Mechanism… Contd. 2. Without Pupillary block- Plateau iris syndrome, malignant glaucoma, forward vitreous shift, scleral buckling, following PRP, CRVO, Intra ocular tumours , cysts of iris & ciliary body, ROP, PHPV
September 24,2006
Dr Sanjay Shrivastava
17
Pupillary Block Glaucoma Is characterized by functional block between pupillary border of iris and ant lens surface, usually associated with mid dilated pupil. This leads to build up of aqueous pressure in posterior chamber leading to forward shift of the peripheral iris and a closed anterior chamber.
September 24,2006
Dr Sanjay Shrivastava
18
Theories of mechanism of angle closure glaucoma • Relative Pupillary Block: Increased resistance to aqueous flow from posterior to anterior chamber between iris and lens , the musculature of iris exert a backward pressure against the lens that increases the resistance to flow of aqueous into AC resulting in increase in pressure in PC causes forward bulge in peripheral iris. September 24,2006
Dr Sanjay Shrivastava
19
Stages of Angle Closure 1. Iridocorneal contact 2. Iridotrabecular contact
September 24,2006
Dr Sanjay Shrivastava
20
Anatomical Risk Factors for Pupillary Block • Shallow AC, Thick anteriorly placed lens , smaller diameter of cornea, shorter posterior curvature of cornea, shorter axial length , relative anterior insertion of iris, narrow angle of AC and loose zonular ligaments.
September 24,2006
Dr Sanjay Shrivastava
21
Pupillary Dilatation • Mid dilated pupil of 3.5 to 6 mm is critical limit of dilatation to cause acute attack • Pupillary block force of dilator and sphincter muscle and stretching force of iris are greatest on iris in mid dilated position (of 3.5 to 4.5 mm size)
September 24,2006
Dr Sanjay Shrivastava
22
Mechanism of Chronic Angle Closure Glaucoma • Peripheral Anterior Synechiae (PAS) may develop with prolonged or recurrent acute or subacute attack leading to chronic angle closure glaucoma • PAS in acute angle closure are broad based and are seen in superior quadrant and correlate with duration of acute attack
September 24,2006
Dr Sanjay Shrivastava
23
Mechanism of Chronic Angle Closure Glaucoma • Synechial closure is referred to as shortening of the angle – creeping angle closure. This condition can be prevented by timely peripheral iridotomy.
September 24,2006
Dr Sanjay Shrivastava
24
Irido- corneal Contact Ten major factors may combine to produce irido-corneal contact: Static factors 1. Curvature of Cornea 2. Curvature of Anterior lens surface 3. Modulus of elasticity of iris stroma
September 24,2006
Dr Sanjay Shrivastava
25
Irido- corneal Contact… Contd Factors that can develop an acute change 4. The sphincter muscle force 5. The dilator muscle force 6. The force that results from iris stromal strech E 7. Anterior Chamber depth
September 24,2006
Dr Sanjay Shrivastava
26
Irido- corneal Contact… Contd Subsidiary factors 8. Aqueous inflow 9. Facility of out flow 10 Pigment release
September 24,2006
Dr Sanjay Shrivastava
27
Occludable Angle • Occludable angle is the eye in which the pigmented trabecular meshwork is not visible without indentation in atleast 3 out of 4 quadrants. The drainage angle in such eyes is generally grade II or less i.e. less than 20 degrees. No other gonioscopic abnormality is present
September 24,2006
Dr Sanjay Shrivastava
28
Occludable Angle • Some reports have concluded that considering definition of occludable angle for epidemiological studies will lead to misclassification of many subject with PACG as POAG as the current definition of occludable angle is too stringent. According to these authors history, clinical examination and static and dynamic gonioscopy remains the diagnostic gold standard. (Foster P.J. et al 2003). September 24,2006
Dr Sanjay Shrivastava
29
Types of Angle Closure Glaucoma (Based on symptoms and Clinical Findings) 2. Acute angle closure glaucoma 3. Sub-acute angle closure glaucoma (also called intermittent/ prodromal or subclinical glaucoma). Sub-acute glaucoma may lead to acute angle closure glaucoma or chronic angle closure glaucoma September 24,2006
Dr Sanjay Shrivastava
30
Types of Angle Closure Glaucoma 3.Chronic Angle Closure Glaucoma 4. Combined Mechanism Glaucoma
September 24,2006
Dr Sanjay Shrivastava
31
Plateau Iris Plateau Iris Configuration and Plateau Iris Syndrome • The definitions of these entities are included here because they are primary conditions that are often difficult to distinguish from the PAC entities resulting from pupillary block.
September 24,2006
Dr Sanjay Shrivastava
32
Plateau Iris Plateau iris configuration is characterized by a near-normal-depth central anterior chamber, a flat iris profile, and crowding of the anteriorchamber angle by the iris base. The IOP may be normal or elevated. The condition appears to be related to a forward displacement of the ciliary processes that causes anterior displacement of the peripheral iris and angle closure. Such closure occurs without a significant pupillary block component. September 24,2006
Dr Sanjay Shrivastava
33
Plateau Iris • Plateau iris syndrome is defined as having a plateau iris configuration with a closed anteriorchamber angle and usually with elevated IOP, which persists despite the elimination of any pupillary block component by a patent iridotomy. Intraocular pressure elevation that was present before iridotomy may persist; the IOP typically increases after pupil dilation, which causes greater occlusion of the angle by the peripheral iris. September 24,2006
Dr Sanjay Shrivastava
34
Combined Mechanism Glaucomas • Combined mechanism glaucomas refers to condition in which both, open angle and angle closure components are present • After successful treatment of angle closure glaucoma with iridotomy , eliminating all appositional closure the IOP still remains elevated. PAS may or may not be present
September 24,2006
Dr Sanjay Shrivastava
35
Combined Mechanism Glaucomas • An eye with open angle glaucoma may develop angle closure due to natural development of pupillary block or result from miotic therapy
September 24,2006
Dr Sanjay Shrivastava
36
Mechanism of Combined Glaucoma I. Open angle glaucoma complicated by angle closure • Co-incidental occurrence • Miotic induced • Swelling of lens • Flat AC after intraocular surgery • PAS after ALT, PAS following inflammation September 24,2006
Dr Sanjay Shrivastava
37
Mechanism of Combined Glaucoma II Primary angle closure with trabecular damage (due to acute, sub-acute or chronic angle closure) III Secondary open angle glaucoma with superimposed secondary angle closure glaucoma (post traumatic , idiopathic, uveitic glaucoma is complicated by PAS due to recurrence of inflammation) September 24,2006
Dr Sanjay Shrivastava
38
Mechanism of Combined Glaucoma IV Primary open angle glaucoma with superimposed secondary open angle glaucoma (Secondary to trauma or inflammation) V. Elevated episcleral venous pressure casing impaired outflow facility (Thyroid Ophthalmopathy, Carotico cavernous fistula, Struge Weber Syndrome) September 24,2006
Dr Sanjay Shrivastava
39
Diagnostic Situations • During the course of ocular examination, on the basis of suspicious findings • Patient may present with symptoms and signs suggestive of angle closure glaucoma.
September 24,2006
Dr Sanjay Shrivastava
40
Risk Factors I.
General Features of Patients a. Age: Bimodal peak, at ages 53 – 58 years and at 63-70 years b. Race: Less common amongst black c. Sex: significant predominance of females d. Refractive Error: More common in hypermetropes
September 24,2006
Dr Sanjay Shrivastava
41
Risk Factors e. Family History: generally believed to be inherited f. Systemic disorders: type II Diabetes is associated with decreased anterior chamber depth
September 24,2006
Dr Sanjay Shrivastava
42
Precipitating Factors I Factors that produce mydriasis a. Dim illumination b. Emotional stress c. Drugs (Mydriatics – anticholinergics including Botulinum toxin and adrenergics
September 24,2006
Dr Sanjay Shrivastava
43
Precipitating Factors II Factors that produce miosis, strong cholinesterase inhibitor miotics like diisopropyl fluorophosphate and ecothiophate iodide III Sulpha based compound that produce transient myopia due to lens swelling and forward movement of lens iris diaphragm September 24,2006
Dr Sanjay Shrivastava
44
Clinical Features OCULAR FINDINGS a. Intraocular tension (IOT) – tonometry, tonography b. Evaluation of peripheral anterior chamber * Penlight examination * Slit lamp examination for peripheral anterior chamber depth September 24,2006
Dr Sanjay Shrivastava
45
Clinical Features .. contd Slit Lamp examination (ven Herick’s method) Grade IV or larger – PAC > or equal to 1CT Grade III – PAC = ¼ - ½ CT Grade II – PAC = ¼ CT Grade I – PAC < ¼ CT September 24,2006
Dr Sanjay Shrivastava
46
Clinical Features … contd Slit Lamp examination (van Herick’s method) Peripheral anterior chamber depth of < ¼ is considered dangerously narrow anterior chamber angle * Gonioscopy is indicated particularly when peripheral AC depth is shallow, Static and dynamic (indentation) September 24,2006
Dr Sanjay Shrivastava
47
The Grading System for Van Herick’s Technique Classification - Gonioscopic Appearance Wide open - All structures visible Grade I narrow - Difficult to see over iris root into recess Grade II narrow - Ciliary body band obscured Grade III narrow - Posterior trabeculum obscured Grade IV narrow (closed) - Only Schwalbe’s line visible September 24,2006
Dr Sanjay Shrivastava
48
Gonioscopic Interpretation • Sheie proposed system based on extent of visualization of anterior chamber angle structures. • Shaffer suggested grading on the basis of angular width of angle recess • Spaeth suggested evaluation of angular width of angle recess, configuration of peripheral iris and apparent insertion of iris root. September 24,2006
Dr Sanjay Shrivastava
49
Newer Techniques • • • •
Ultrasound Biomicroscopy Radioimaging OCT Optic nerve head (ONH) and retinal nerve fiber layer (RNFL) assessments
September 24,2006
Dr Sanjay Shrivastava
50
ONH and layer RNFL assessments Qualitative o Slit lamp biomicroscopy examination using non-contact lenses (eg, 90-D lens) or contact lenses (eg, central lens in Goldmann 3-mirror lens). Green filter may aid in the identification of RNFL thinning. o Fundus photography for documentation (stereoscopic or nonstereoscopic) September 24,2006
Dr Sanjay Shrivastava
51
ONH and layer RNFL assessments Quantitative o GDx VCC nerve fiber analyzer o Heidelberg retinal tomography (HRT) o Optical coherence tomography (OCT)
September 24,2006
Dr Sanjay Shrivastava
52
Shaffer’s Gonioscopic Classification of the Anterior Chamber Angle • Grade Angular Width Clinical Interpretation • A Wide open (20° to 45° Closure improbable • B Moderately narrow (10° to 20°) Closure possible • C Extremely narrow Closure possible • D Partially/totally closed Closure present September 24,2006
Dr Sanjay Shrivastava
53
Spaeth’s Gonioscopic Classification of the Anterior Chamber Angle Site of iris insertion Anterior to trabecular meshwork, Schwalbe's line Behind Schwalbe's line, trabecular meshwork Scleral spur Deep angle recess, anterior ciliary body band Extremely deep, posterior ciliary body band September 24,2006
Dr Sanjay Shrivastava
54
Peripheral iris configuration • • • •
b = bowed f = flat p = plateau c = concave
• Degree of iris bowing (IB): 0 to 4+
September 24,2006
Dr Sanjay Shrivastava
55
Provocative tests 1. Mydraitic Provocative test: topical Tropicamide 1% rise of IOT of 8 mm of Hg or more is considered positive test. 2. Dark Room Provocative test: Exposure to dark for 60 – 90 min – rise of 8 mm of Hg or more is considered positive test. 3. Prone Provocative test : Prone position for 60 min , rise of 8 mm of Hg or more is considered positive test September 24,2006
Dr Sanjay Shrivastava
56
Provocative tests … contd 4. Pilocarpine/Phenylephrine Provocative Test: 2% Pilocarpine and 10% Phenylephrine are instilled simultaneously every minute for 3 applications to achieve mid dilated pupil – rise of 8 mm of Hg or more is considered positive test.If negative repeat the test . If negative after 90 min, test is terminated by 0.5% Thymoxamine (alpha adrenergic agonist) September 24,2006
Dr Sanjay Shrivastava
57
Value of Provocative Tests Questionable Accurate history and meticulous physical examination provides the best guide.
September 24,2006
Dr Sanjay Shrivastava
58
Symptoms of Angle Closure Glaucoma • Sub-acute angle closure Glaucoma – dull ache, slight blurring • Acute angle closure Glaucoma – Pain, redness, blurred vision • Chronic angle closure glaucoma – Asymptomatic or visual field defects
September 24,2006
Dr Sanjay Shrivastava
59
Signs 1. External Ocular Examination 2. Slit lamp examination 3. Gonioscopy including compressive gonioscopy to differentiate appositional angle closure from synechial closure 4. Fundus examination (Hyperaemic and edematous disc. CRVO may occur during acute angle closure glaucoma September 24,2006
Dr Sanjay Shrivastava
60
Signs 5. Visual fields shows non-specific constriction. It may be constriction of upper field or nerve fibre bundle defect.
September 24,2006
Dr Sanjay Shrivastava
61
Differential Diagnosis of acute angle closure Glaucoma 1. Neovascular Glaucoma 2. Inflammatory causes (Post synechiae , iris bombe) 3. Iridocorneal endothelial Syndrome (ICE) 4. Ciliary body engorgement or suprachoroidal effusion caused by systemic drugs like Topiramate, Sulphonamide and Phenothiazine September 24,2006
Dr Sanjay Shrivastava
62
Differential Diagnosis of acute angle closure Glaucoma 5. Ciliary body engorgement associated with retinal vein occlusion or PRP 6. Ciliary body block syndrome 7. After incisional or LASER PI 8. Phacomorphic lens induced glaucoma
September 24,2006
Dr Sanjay Shrivastava
63
Differential Diagnosis of acute angle closure Glaucoma 9. Developmental anomalies like nanophthalmos, ROP, PHPV 10. Iris or ciliary body mass lesion 11. Open angle glaucoma.
September 24,2006
Dr Sanjay Shrivastava
64
Management
September 24,2006
Dr Sanjay Shrivastava
65
Management Goals • Identification of patients at risk of developing primary angle closure (PAC) glaucoma or to identify patients with PAC • To manage an acute attack • To prevent permanent damage to angle of anterior chamber • To ensure that patient leads a symptom free life September 24,2006
Dr Sanjay Shrivastava
66
Management Goals • To determine other mechanism of angle closure glaucoma than pupillary block • To reverse or prevent angle closure by LASER PI or incisional iridectomy • To determine residual angle closure after iridotomy • To observe for chronic IOP elevation, progression of synechial angle closure / optic nerve damage and treat as indicated September 24,2006
Dr Sanjay Shrivastava
67
MEDICAL THERAPY Approaches e. To reduce IOP f. To relieve the angle closure
September 24,2006
Dr Sanjay Shrivastava
68
a. Reduction of IOP • ORAL THERAPY 1. Acetazolamide 2. Glycerol 3. Isosorbid • INTRAVENOUS THERAPY 1. Mannitol 2. Acetazolamide September 24,2006
Dr Sanjay Shrivastava
69
a. Reduction of IOP TOPICAL THERAPY 2. Beta-adrenergic blockers 3. Alpha 2 Adrenergic Agonist 4. Topical carbonic anhydrase inhibitor 5. Topical miotic
September 24,2006
Dr Sanjay Shrivastava
70
b. Relief of Angle Closure 1. Pilocarpine 1 or 2 % 2. Topical thymoxamine 0.5% (Eserine and Echothiopate Iodide are not indicated) 3. LASER PI 4. If not possible then surgical / incisional iridectomy 5. Lensectomy September 24,2006
Dr Sanjay Shrivastava
71
Prophylactic Iridotomy • Previously normal IOP is elevated • A potentially occludable angle is present • PAS that are attributable to episodes of angle closure are present • There is progressive narrowing of the angle • Medication is required that may provoke pupillary block • Symptoms are present that suggest prior angle closure September 24,2006
Dr Sanjay Shrivastava
72
Prophylactic Iridotomy • The patient's occupation/avocation makes it difficult to access immediate ophthalmic care (e.g., the patient travels frequently to developing parts of the world or works on a merchant vessel). • For the fellow eye in patients who have had an attack of acute PAC (as described in the section about “acute primary angle closure” under Orientation). September 24,2006
Dr Sanjay Shrivastava
73
Follow-up Protocol • Follow up to evaluate a. Patency of Iridotomy b. IOP measurement c. Gonioscopy d. Pupillary dilatation to decrease risk of posterior synechiae f. Fundus examination September 24,2006
Dr Sanjay Shrivastava
74
Follow up Protocol • Patient should be examined to evaluate history and ocular examination at one week to 4 months if target IOP has been achieved but if damage is progressive every 3 months to every 12 months if target IOP has been achieved and no progressive damage.
September 24,2006
Dr Sanjay Shrivastava
75
Follow up Protocol • If target IOP has not been achieved then patient should be followed up frequently • Optic Disc should be evaluated after every 2 –12 months interval and visual field should be checked every 1 to 6 months depending on achieving target IOP
September 24,2006
Dr Sanjay Shrivastava
76
Counseling • Patient at risk may be warned about taking decongestants, motion sickness medication and Anticholinergic agents. Patients should be informed about symptoms of acute angle closure glaucoma and to consult Ophthalmologist immediately if symptoms occur.
September 24,2006
Dr Sanjay Shrivastava
77
Dr Sanjay Shrivastava
1
Definition • Angle Closure Glaucomas are characterized by apposition of peripheral iris against trabecular meshwork, resulting in obstruction of aqueous outflow.
September 24,2006
Dr Sanjay Shrivastava
2
• Primary Angle Closure Glaucoma term is used when mechanism of angle closure glaucoma is not felt to be associated with other ocular or systemic abnormalities or because the mechanisms are not well understood. In this condition pupillary block glaucoma, plateau iris and combined mechanism glaucoma have been included. September 24,2006
Dr Sanjay Shrivastava
3
• Secondary Angle Closure Glaucoma is associated with ocular or systemic abnormalities or due to apparent mechanism such as membrane contraction or space occupying lesions pushing iris forward to close angle.
September 24,2006
Dr Sanjay Shrivastava
4
Epidemiology • Glaucoma is second leading cause of blindness world wide. It has been estimated that by 2010 there will be 60.5 million glaucoma affected people with approximately 26% with angle closure glaucoma. • Angle closure glaucoma is less common than chronic open angle glaucoma. • Angle closure glaucoma is common among Asians and Eskimos but uncommon among Africans and Caucasians September 24,2006
Dr Sanjay Shrivastava
5
Epidemiology • The precise ratio between the two has not been established. Reported figures from some of the western countries indicates incidence of angle closure glaucoma as 0.5% in general population and 2-3 % in >40 years age group. • Prevalence of 1.58% has been reported in rural south Indian population by Lingam & co-workers (2006) September 24,2006
Dr Sanjay Shrivastava
6
Epidemiology • West Bengal study has reported glaucoma in 2.63% cases in 1594 individuals >50 years examined. • Another study has estimated that ½ of 67 million people diagnosed with glaucoma has primary angle closure glaucoma. According to this study 6.7 million people globally are irreversibly blind due glaucoma. September 24,2006
Dr Sanjay Shrivastava
7
Stages of Glaucoma 1. Initiating events 2. Structural alterations 3. Functional alterations 4. Optic nerve damage 5. Visual loss
September 24,2006
Dr Sanjay Shrivastava
8
Stages of Glaucoma Stages representing: * The series of events, leading to * Tissue changes, leading to * Physiologic changes, leading to * Axonal loss, leading to * Visual field loss (progressive)
September 24,2006
Dr Sanjay Shrivastava
9
Stages of Glaucoma * Stage I – Initiating events may be genetic or acquired * Stage II- Tissue changes are associated with aqueous outflow system with vascular and structural alteration in optic nerve head. * Stage III- Physiologic changes are associated with elevated IOT, reduced vascular perfusion, laminar deformity
September 24,2006
Dr Sanjay Shrivastava
10
Stages of Glaucoma * Stage IV – Axonal Loss leads to *Stage V - Glaucomatous optic neuropathy that is associated with Glaucomatous field loss
September 24,2006
Dr Sanjay Shrivastava
11
Classification of the Glaucomas Based on Initial events A. Open Angle Glaucomas B. Angle Closure Glaucomas 1. Pupillary Block Glaucoma 2. Plateau Iris Syndrome 3. Combined mechanism Glaucomas C. Developmental Glaucomas D. Glaucomas Associated with other ocular and systemic disorders September 24,2006
Dr Sanjay Shrivastava
12
Pupillary Block Glaucoma • Also called primary angle closure Glaucomas – Acute – Sub-acute – Chronic angle closure • Creeping angle closure • Combined mechanism glaucoma
September 24,2006
Dr Sanjay Shrivastava
13
Classification of the Glaucomas based on mechanism of outflow obstruction I. Open Angle Glaucoma mechanism II. Angle Closure Glaucoma Mechanism III. Developmental Anomalies of the Anterior Chamber Angle
September 24,2006
Dr Sanjay Shrivastava
14
Angle Closure Glaucoma Mechanism A. Anterior (Pulling Mechanism) 1. Contracture of Membranes (Neovascular Glaucoma, ICE Syndrome, Post polymorphous dystrophy, Ocular Trauma) 2. Contracture of Inflammatory precipitates
September 24,2006
Dr Sanjay Shrivastava
15
Angle Closure Glaucoma Mechanism… Contd. B. Posterior (Pushing Mechanism) 1. With Pupillary block : Pupillary Block Glaucoma- Lens Induced Mechanism (Intumescent lens, subluxation of lens, mobile lens syndrome), Post synechiae (Iris-vitreous block, pseudophakia, Uvietis)
September 24,2006
Dr Sanjay Shrivastava
16
Angle Closure Glaucoma Mechanism… Contd. 2. Without Pupillary block- Plateau iris syndrome, malignant glaucoma, forward vitreous shift, scleral buckling, following PRP, CRVO, Intra ocular tumours , cysts of iris & ciliary body, ROP, PHPV
September 24,2006
Dr Sanjay Shrivastava
17
Pupillary Block Glaucoma Is characterized by functional block between pupillary border of iris and ant lens surface, usually associated with mid dilated pupil. This leads to build up of aqueous pressure in posterior chamber leading to forward shift of the peripheral iris and a closed anterior chamber.
September 24,2006
Dr Sanjay Shrivastava
18
Theories of mechanism of angle closure glaucoma • Relative Pupillary Block: Increased resistance to aqueous flow from posterior to anterior chamber between iris and lens , the musculature of iris exert a backward pressure against the lens that increases the resistance to flow of aqueous into AC resulting in increase in pressure in PC causes forward bulge in peripheral iris. September 24,2006
Dr Sanjay Shrivastava
19
Stages of Angle Closure 1. Iridocorneal contact 2. Iridotrabecular contact
September 24,2006
Dr Sanjay Shrivastava
20
Anatomical Risk Factors for Pupillary Block • Shallow AC, Thick anteriorly placed lens , smaller diameter of cornea, shorter posterior curvature of cornea, shorter axial length , relative anterior insertion of iris, narrow angle of AC and loose zonular ligaments.
September 24,2006
Dr Sanjay Shrivastava
21
Pupillary Dilatation • Mid dilated pupil of 3.5 to 6 mm is critical limit of dilatation to cause acute attack • Pupillary block force of dilator and sphincter muscle and stretching force of iris are greatest on iris in mid dilated position (of 3.5 to 4.5 mm size)
September 24,2006
Dr Sanjay Shrivastava
22
Mechanism of Chronic Angle Closure Glaucoma • Peripheral Anterior Synechiae (PAS) may develop with prolonged or recurrent acute or subacute attack leading to chronic angle closure glaucoma • PAS in acute angle closure are broad based and are seen in superior quadrant and correlate with duration of acute attack
September 24,2006
Dr Sanjay Shrivastava
23
Mechanism of Chronic Angle Closure Glaucoma • Synechial closure is referred to as shortening of the angle – creeping angle closure. This condition can be prevented by timely peripheral iridotomy.
September 24,2006
Dr Sanjay Shrivastava
24
Irido- corneal Contact Ten major factors may combine to produce irido-corneal contact: Static factors 1. Curvature of Cornea 2. Curvature of Anterior lens surface 3. Modulus of elasticity of iris stroma
September 24,2006
Dr Sanjay Shrivastava
25
Irido- corneal Contact… Contd Factors that can develop an acute change 4. The sphincter muscle force 5. The dilator muscle force 6. The force that results from iris stromal strech E 7. Anterior Chamber depth
September 24,2006
Dr Sanjay Shrivastava
26
Irido- corneal Contact… Contd Subsidiary factors 8. Aqueous inflow 9. Facility of out flow 10 Pigment release
September 24,2006
Dr Sanjay Shrivastava
27
Occludable Angle • Occludable angle is the eye in which the pigmented trabecular meshwork is not visible without indentation in atleast 3 out of 4 quadrants. The drainage angle in such eyes is generally grade II or less i.e. less than 20 degrees. No other gonioscopic abnormality is present
September 24,2006
Dr Sanjay Shrivastava
28
Occludable Angle • Some reports have concluded that considering definition of occludable angle for epidemiological studies will lead to misclassification of many subject with PACG as POAG as the current definition of occludable angle is too stringent. According to these authors history, clinical examination and static and dynamic gonioscopy remains the diagnostic gold standard. (Foster P.J. et al 2003). September 24,2006
Dr Sanjay Shrivastava
29
Types of Angle Closure Glaucoma (Based on symptoms and Clinical Findings) 2. Acute angle closure glaucoma 3. Sub-acute angle closure glaucoma (also called intermittent/ prodromal or subclinical glaucoma). Sub-acute glaucoma may lead to acute angle closure glaucoma or chronic angle closure glaucoma September 24,2006
Dr Sanjay Shrivastava
30
Types of Angle Closure Glaucoma 3.Chronic Angle Closure Glaucoma 4. Combined Mechanism Glaucoma
September 24,2006
Dr Sanjay Shrivastava
31
Plateau Iris Plateau Iris Configuration and Plateau Iris Syndrome • The definitions of these entities are included here because they are primary conditions that are often difficult to distinguish from the PAC entities resulting from pupillary block.
September 24,2006
Dr Sanjay Shrivastava
32
Plateau Iris Plateau iris configuration is characterized by a near-normal-depth central anterior chamber, a flat iris profile, and crowding of the anteriorchamber angle by the iris base. The IOP may be normal or elevated. The condition appears to be related to a forward displacement of the ciliary processes that causes anterior displacement of the peripheral iris and angle closure. Such closure occurs without a significant pupillary block component. September 24,2006
Dr Sanjay Shrivastava
33
Plateau Iris • Plateau iris syndrome is defined as having a plateau iris configuration with a closed anteriorchamber angle and usually with elevated IOP, which persists despite the elimination of any pupillary block component by a patent iridotomy. Intraocular pressure elevation that was present before iridotomy may persist; the IOP typically increases after pupil dilation, which causes greater occlusion of the angle by the peripheral iris. September 24,2006
Dr Sanjay Shrivastava
34
Combined Mechanism Glaucomas • Combined mechanism glaucomas refers to condition in which both, open angle and angle closure components are present • After successful treatment of angle closure glaucoma with iridotomy , eliminating all appositional closure the IOP still remains elevated. PAS may or may not be present
September 24,2006
Dr Sanjay Shrivastava
35
Combined Mechanism Glaucomas • An eye with open angle glaucoma may develop angle closure due to natural development of pupillary block or result from miotic therapy
September 24,2006
Dr Sanjay Shrivastava
36
Mechanism of Combined Glaucoma I. Open angle glaucoma complicated by angle closure • Co-incidental occurrence • Miotic induced • Swelling of lens • Flat AC after intraocular surgery • PAS after ALT, PAS following inflammation September 24,2006
Dr Sanjay Shrivastava
37
Mechanism of Combined Glaucoma II Primary angle closure with trabecular damage (due to acute, sub-acute or chronic angle closure) III Secondary open angle glaucoma with superimposed secondary angle closure glaucoma (post traumatic , idiopathic, uveitic glaucoma is complicated by PAS due to recurrence of inflammation) September 24,2006
Dr Sanjay Shrivastava
38
Mechanism of Combined Glaucoma IV Primary open angle glaucoma with superimposed secondary open angle glaucoma (Secondary to trauma or inflammation) V. Elevated episcleral venous pressure casing impaired outflow facility (Thyroid Ophthalmopathy, Carotico cavernous fistula, Struge Weber Syndrome) September 24,2006
Dr Sanjay Shrivastava
39
Diagnostic Situations • During the course of ocular examination, on the basis of suspicious findings • Patient may present with symptoms and signs suggestive of angle closure glaucoma.
September 24,2006
Dr Sanjay Shrivastava
40
Risk Factors I.
General Features of Patients a. Age: Bimodal peak, at ages 53 – 58 years and at 63-70 years b. Race: Less common amongst black c. Sex: significant predominance of females d. Refractive Error: More common in hypermetropes
September 24,2006
Dr Sanjay Shrivastava
41
Risk Factors e. Family History: generally believed to be inherited f. Systemic disorders: type II Diabetes is associated with decreased anterior chamber depth
September 24,2006
Dr Sanjay Shrivastava
42
Precipitating Factors I Factors that produce mydriasis a. Dim illumination b. Emotional stress c. Drugs (Mydriatics – anticholinergics including Botulinum toxin and adrenergics
September 24,2006
Dr Sanjay Shrivastava
43
Precipitating Factors II Factors that produce miosis, strong cholinesterase inhibitor miotics like diisopropyl fluorophosphate and ecothiophate iodide III Sulpha based compound that produce transient myopia due to lens swelling and forward movement of lens iris diaphragm September 24,2006
Dr Sanjay Shrivastava
44
Clinical Features OCULAR FINDINGS a. Intraocular tension (IOT) – tonometry, tonography b. Evaluation of peripheral anterior chamber * Penlight examination * Slit lamp examination for peripheral anterior chamber depth September 24,2006
Dr Sanjay Shrivastava
45
Clinical Features .. contd Slit Lamp examination (ven Herick’s method) Grade IV or larger – PAC > or equal to 1CT Grade III – PAC = ¼ - ½ CT Grade II – PAC = ¼ CT Grade I – PAC < ¼ CT September 24,2006
Dr Sanjay Shrivastava
46
Clinical Features … contd Slit Lamp examination (van Herick’s method) Peripheral anterior chamber depth of < ¼ is considered dangerously narrow anterior chamber angle * Gonioscopy is indicated particularly when peripheral AC depth is shallow, Static and dynamic (indentation) September 24,2006
Dr Sanjay Shrivastava
47
The Grading System for Van Herick’s Technique Classification - Gonioscopic Appearance Wide open - All structures visible Grade I narrow - Difficult to see over iris root into recess Grade II narrow - Ciliary body band obscured Grade III narrow - Posterior trabeculum obscured Grade IV narrow (closed) - Only Schwalbe’s line visible September 24,2006
Dr Sanjay Shrivastava
48
Gonioscopic Interpretation • Sheie proposed system based on extent of visualization of anterior chamber angle structures. • Shaffer suggested grading on the basis of angular width of angle recess • Spaeth suggested evaluation of angular width of angle recess, configuration of peripheral iris and apparent insertion of iris root. September 24,2006
Dr Sanjay Shrivastava
49
Newer Techniques • • • •
Ultrasound Biomicroscopy Radioimaging OCT Optic nerve head (ONH) and retinal nerve fiber layer (RNFL) assessments
September 24,2006
Dr Sanjay Shrivastava
50
ONH and layer RNFL assessments Qualitative o Slit lamp biomicroscopy examination using non-contact lenses (eg, 90-D lens) or contact lenses (eg, central lens in Goldmann 3-mirror lens). Green filter may aid in the identification of RNFL thinning. o Fundus photography for documentation (stereoscopic or nonstereoscopic) September 24,2006
Dr Sanjay Shrivastava
51
ONH and layer RNFL assessments Quantitative o GDx VCC nerve fiber analyzer o Heidelberg retinal tomography (HRT) o Optical coherence tomography (OCT)
September 24,2006
Dr Sanjay Shrivastava
52
Shaffer’s Gonioscopic Classification of the Anterior Chamber Angle • Grade Angular Width Clinical Interpretation • A Wide open (20° to 45° Closure improbable • B Moderately narrow (10° to 20°) Closure possible • C Extremely narrow Closure possible • D Partially/totally closed Closure present September 24,2006
Dr Sanjay Shrivastava
53
Spaeth’s Gonioscopic Classification of the Anterior Chamber Angle Site of iris insertion Anterior to trabecular meshwork, Schwalbe's line Behind Schwalbe's line, trabecular meshwork Scleral spur Deep angle recess, anterior ciliary body band Extremely deep, posterior ciliary body band September 24,2006
Dr Sanjay Shrivastava
54
Peripheral iris configuration • • • •
b = bowed f = flat p = plateau c = concave
• Degree of iris bowing (IB): 0 to 4+
September 24,2006
Dr Sanjay Shrivastava
55
Provocative tests 1. Mydraitic Provocative test: topical Tropicamide 1% rise of IOT of 8 mm of Hg or more is considered positive test. 2. Dark Room Provocative test: Exposure to dark for 60 – 90 min – rise of 8 mm of Hg or more is considered positive test. 3. Prone Provocative test : Prone position for 60 min , rise of 8 mm of Hg or more is considered positive test September 24,2006
Dr Sanjay Shrivastava
56
Provocative tests … contd 4. Pilocarpine/Phenylephrine Provocative Test: 2% Pilocarpine and 10% Phenylephrine are instilled simultaneously every minute for 3 applications to achieve mid dilated pupil – rise of 8 mm of Hg or more is considered positive test.If negative repeat the test . If negative after 90 min, test is terminated by 0.5% Thymoxamine (alpha adrenergic agonist) September 24,2006
Dr Sanjay Shrivastava
57
Value of Provocative Tests Questionable Accurate history and meticulous physical examination provides the best guide.
September 24,2006
Dr Sanjay Shrivastava
58
Symptoms of Angle Closure Glaucoma • Sub-acute angle closure Glaucoma – dull ache, slight blurring • Acute angle closure Glaucoma – Pain, redness, blurred vision • Chronic angle closure glaucoma – Asymptomatic or visual field defects
September 24,2006
Dr Sanjay Shrivastava
59
Signs 1. External Ocular Examination 2. Slit lamp examination 3. Gonioscopy including compressive gonioscopy to differentiate appositional angle closure from synechial closure 4. Fundus examination (Hyperaemic and edematous disc. CRVO may occur during acute angle closure glaucoma September 24,2006
Dr Sanjay Shrivastava
60
Signs 5. Visual fields shows non-specific constriction. It may be constriction of upper field or nerve fibre bundle defect.
September 24,2006
Dr Sanjay Shrivastava
61
Differential Diagnosis of acute angle closure Glaucoma 1. Neovascular Glaucoma 2. Inflammatory causes (Post synechiae , iris bombe) 3. Iridocorneal endothelial Syndrome (ICE) 4. Ciliary body engorgement or suprachoroidal effusion caused by systemic drugs like Topiramate, Sulphonamide and Phenothiazine September 24,2006
Dr Sanjay Shrivastava
62
Differential Diagnosis of acute angle closure Glaucoma 5. Ciliary body engorgement associated with retinal vein occlusion or PRP 6. Ciliary body block syndrome 7. After incisional or LASER PI 8. Phacomorphic lens induced glaucoma
September 24,2006
Dr Sanjay Shrivastava
63
Differential Diagnosis of acute angle closure Glaucoma 9. Developmental anomalies like nanophthalmos, ROP, PHPV 10. Iris or ciliary body mass lesion 11. Open angle glaucoma.
September 24,2006
Dr Sanjay Shrivastava
64
Management
September 24,2006
Dr Sanjay Shrivastava
65
Management Goals • Identification of patients at risk of developing primary angle closure (PAC) glaucoma or to identify patients with PAC • To manage an acute attack • To prevent permanent damage to angle of anterior chamber • To ensure that patient leads a symptom free life September 24,2006
Dr Sanjay Shrivastava
66
Management Goals • To determine other mechanism of angle closure glaucoma than pupillary block • To reverse or prevent angle closure by LASER PI or incisional iridectomy • To determine residual angle closure after iridotomy • To observe for chronic IOP elevation, progression of synechial angle closure / optic nerve damage and treat as indicated September 24,2006
Dr Sanjay Shrivastava
67
MEDICAL THERAPY Approaches e. To reduce IOP f. To relieve the angle closure
September 24,2006
Dr Sanjay Shrivastava
68
a. Reduction of IOP • ORAL THERAPY 1. Acetazolamide 2. Glycerol 3. Isosorbid • INTRAVENOUS THERAPY 1. Mannitol 2. Acetazolamide September 24,2006
Dr Sanjay Shrivastava
69
a. Reduction of IOP TOPICAL THERAPY 2. Beta-adrenergic blockers 3. Alpha 2 Adrenergic Agonist 4. Topical carbonic anhydrase inhibitor 5. Topical miotic
September 24,2006
Dr Sanjay Shrivastava
70
b. Relief of Angle Closure 1. Pilocarpine 1 or 2 % 2. Topical thymoxamine 0.5% (Eserine and Echothiopate Iodide are not indicated) 3. LASER PI 4. If not possible then surgical / incisional iridectomy 5. Lensectomy September 24,2006
Dr Sanjay Shrivastava
71
Prophylactic Iridotomy • Previously normal IOP is elevated • A potentially occludable angle is present • PAS that are attributable to episodes of angle closure are present • There is progressive narrowing of the angle • Medication is required that may provoke pupillary block • Symptoms are present that suggest prior angle closure September 24,2006
Dr Sanjay Shrivastava
72
Prophylactic Iridotomy • The patient's occupation/avocation makes it difficult to access immediate ophthalmic care (e.g., the patient travels frequently to developing parts of the world or works on a merchant vessel). • For the fellow eye in patients who have had an attack of acute PAC (as described in the section about “acute primary angle closure” under Orientation). September 24,2006
Dr Sanjay Shrivastava
73
Follow-up Protocol • Follow up to evaluate a. Patency of Iridotomy b. IOP measurement c. Gonioscopy d. Pupillary dilatation to decrease risk of posterior synechiae f. Fundus examination September 24,2006
Dr Sanjay Shrivastava
74
Follow up Protocol • Patient should be examined to evaluate history and ocular examination at one week to 4 months if target IOP has been achieved but if damage is progressive every 3 months to every 12 months if target IOP has been achieved and no progressive damage.
September 24,2006
Dr Sanjay Shrivastava
75
Follow up Protocol • If target IOP has not been achieved then patient should be followed up frequently • Optic Disc should be evaluated after every 2 –12 months interval and visual field should be checked every 1 to 6 months depending on achieving target IOP
September 24,2006
Dr Sanjay Shrivastava
76
Counseling • Patient at risk may be warned about taking decongestants, motion sickness medication and Anticholinergic agents. Patients should be informed about symptoms of acute angle closure glaucoma and to consult Ophthalmologist immediately if symptoms occur.
September 24,2006
Dr Sanjay Shrivastava
77
Related Documents
Angle Closure Glaucoma- Current Concepts
November 2019 5
Primary Angle Closure Glaucoma For Ugs
May 2020 4
Concepts Of Closure
June 2020 3
Glaucoma
December 2019 27
Glaucoma
October 2019 24